Metabolic dysfunction following weight cycling in male mice

Int J Obes (Lond). 2017 Mar;41(3):402-411. doi: 10.1038/ijo.2016.193. Epub 2016 Nov 14.

Abstract

Background: Combatting overweight or obesity can lead to large fluctuations in an individual's body weight, often referred to as weight cycling or 'yo-yo' dieting. Current evidence regarding the potentially damaging effects of these changes is conflicting.

Methods: Here, we assess the metabolic effects of weight cycling in a murine model, comprising three dietary switches to normal or high-fat diets at 6 week intervals; male C57BL/6 mice were fed either a control (C) or high-fat (F) diet for 6 weeks (n=140/group). C and F groups were then either maintained on their initial diet (CC and FF, respectively) or switched to a high-fat (CF) or control (FC) diet (n=35/group). For the final 6 week interval, CC and CF groups were returned to the control diet (CCC and CFC groups), while FC and FF groups were placed on a high-fat diet (FCF and FFF) (n=28/group).

Results: For the majority of metabolic outcomes changes aligned with dietary switches; however, assessment of neuropeptides and receptors involved in appetite regulation and reward signalling pathways reveal variable patterns of expression. Furthermore, we demonstrate that multiple cycling events leads to a significant increase in internal fat deposition, even when compared with animals maintained on a high-fat diet (internal fat: FCF: 7.4±0.2 g vs FFF: 5.6±0.2 g; P<0.01).

Conclusions: Increased internal adipose tissue is strongly linked to the development of metabolic syndrome associated conditions such as type 2 diabetes, cardiovascular disease and hypertension. Although further work will be required to elucidate the mechanisms underlying the neuronal control of energy homoeostasis, these studies provide a causative link between weight cycling and adverse health.

MeSH terms

  • Adipose Tissue / metabolism*
  • Animals
  • Diet, Fat-Restricted
  • Diet, High-Fat
  • Disease Models, Animal
  • Energy Intake
  • Energy Metabolism
  • Gastric Inhibitory Polypeptide / metabolism
  • Insulin / metabolism*
  • Interleukin-6 / metabolism
  • Leptin / metabolism
  • Male
  • Metabolic Syndrome / metabolism*
  • Metabolic Syndrome / pathology*
  • Mice
  • Mice, Inbred C57BL
  • Obesity / metabolism
  • Obesity / pathology*
  • Weight Gain / physiology*
  • Weight Loss / physiology*

Substances

  • Insulin
  • Interleukin-6
  • Leptin
  • interleukin-6, mouse
  • Gastric Inhibitory Polypeptide